Suppr超能文献

[113例脉络膜坏死性恶性黑色素瘤的临床和组织病理学特征。2. T细胞受体阳性肿瘤浸润淋巴细胞的免疫遗传学特征及脉络膜坏死性黑色素瘤患者的生存情况]

[Clinical and histopathological aspects of 113 necrotizing malignant melanomas of the choroid. 2. Immunogenetic characterization of T-cell receptor-positive tumor-infiltrating lymphocytes and survival of patients with necrotizing melanomas of the choroid].

作者信息

Bialasiewicz A A, Ma J X, Richard G

机构信息

Augenklinik mit Poliklinik, Universitäts-Krankenhauses Eppendorf, Hamburg.

出版信息

Klin Monbl Augenheilkd. 1998 Nov;213(5):271-7. doi: 10.1055/s-2008-1034987.

Abstract

BACKGROUND

T-cell receptor (TCR) gene analysis of tumor infiltrating lymphocytes (TIL) has been recognized to play a pivotal role in the immunosurveillance of solid neoplasms.

PATIENTS AND METHODS

Therefore, 113 necrotizing choroidal melanomas (NMM) were compared to 100 non-necrotizing melanomas (MM) histologically and immunohistochemically.

RESULTS

NMM showed TIL more frequently (76.11% vs. 21%, p < 0.001). V alpha/V beta- (70.3% of NMM) and V gamma 1- (39.2% of NMM) and V delta 1- (52.7% of NMM) TCR+ cells were distributed focal or diffuse, and correlated with tumor volume, diameter, and scleral invasion. 74.33% of NMM patients had died after 240 months (5 year survival: 58.1%). Mortality was not significantly associated with TIL (p < 0.33) or V alpha/V beta-TCR+ cells (p < 0.2), however, survival was significantly increased with evidence of V gamma 1- and V delta 1-TCR+ cells (p < 0.026).

CONCLUSIONS

V alpha/V beta-, V gamma 1- and V delta 1-TCR+ tumor infiltrating lymphocytes can be demonstrated in choroidal melanomas. This is a basis for functional studies providing a rationale for the evaluation of immunotherapeutic modalities.

摘要

背景

肿瘤浸润淋巴细胞(TIL)的T细胞受体(TCR)基因分析已被认为在实体瘤的免疫监视中起关键作用。

患者与方法

因此,对113例坏死性脉络膜黑色素瘤(NMM)与100例非坏死性黑色素瘤(MM)进行了组织学和免疫组织化学比较。

结果

NMM更频繁地出现TIL(76.11%对21%,p<0.001)。Vα/Vβ-(70.3%的NMM)、Vγ1-(39.2%的NMM)和Vδ1-(52.7%的NMM)TCR+细胞呈局灶性或弥漫性分布,并与肿瘤体积、直径和巩膜侵犯相关。74.33%的NMM患者在240个月后死亡(5年生存率:58.1%)。死亡率与TIL(p<0.33)或Vα/Vβ-TCR+细胞(p<0.2)无显著相关性,然而,Vγ1-和Vδ1-TCR+细胞的存在使生存率显著提高(p<0.026)。

结论

在脉络膜黑色素瘤中可检测到Vα/Vβ-、Vγ1-和Vδ1-TCR+肿瘤浸润淋巴细胞。这为功能研究提供了基础,为评估免疫治疗方式提供了理论依据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验